Psychedelics


A Doctor Explains How Prescribing Ketamine For Depression Works


We spoke with an experienced psychiatrist about how exactly prescribing ketamine for depression works.

Some colleges just don’t understand harm reduction


Clashes between SSDP and New College administrators represent growing confusion about handling harm reduction on campuses

What happens when you give an octopus MDMA?


A team of researchers bathed octopuses in MDMA. Here's what they learned.

A Conversation about Intersectionality in the Psychedelic Community


A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.

Cartoon Dystopia: 25I-NBOMe and Why You Should Test Your LSD


Like the vast majority of psychonauts, I didn’t use a chemical reagent to verify I was taking LSD, even though I had been active in harm reduction work for three years prior and was aware of testing kits.

Adam Strauss on Ketamine for OCD, Trip Sitters, and The Mushroom Cure Los Angeles


Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.

How should we be teaching students about drugs?


Rhana Hashemi is the site coordinator for drug and alcohol programs and services for Oakland Unified School District. But, to her students, she is just “the drug lady.”

How to meditate on psychedelics with Vincent Horn of Meditate.io


Vincent Horn of Meditate.io talks about psychedelics and meditation.

For someone who hasn’t taken a psychedelic drug it can be difficult to imagine what it’s like.


Think of a glass of water: under normal circumstances you might think ‘I drink water when I’m thirsty’. But when consuming a psychedelic substance you might think ’water is the essence of life’.

Salvinorin A. Is it possible to have a truly powerful painkiller that is not addictive?


We need new drugs. The opioid epidemic gripping the United States has brought into public awareness a problem that has bedeviled the world of medical science for decades: is it possible to have a truly powerful painkiller that is not addictive?

Becoming a Psychedelic Researcher: Alan Kooi Davis


Why researchers like Alan Kooi Davis — the newest addition to the Johns Hopkins psychedelic research team — decide to devote their careers to studying psychedelics.

We talked with a researcher using psilocybin for cocaine addiction in Alabama


I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.

LSD Cured My Eating Disorder


As a teenager, I was taking ten milligrams of Ritalin daily. Later, I grew to love the way these pills made it easier for me not to eat.

We now call ‘bad trips’ ‘challenging experiences’. Here’s why that’s misguided.


Renaming adverse effects of psychedelic drugs as “challenging experiences” minimizes, almost trivializes, their negative effects.

Psychedelics and the Full-Fluency Phenomenon


I first discovered the potential psychedelics have for treating stuttering during an experience with psilocybin mushrooms.

Is Ibogaine the Cure for Opioid Addiction? It’s Not That Simple. | Part 11


The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.

Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10


The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.

How Safe is Ibogaine? We Asked Clare Wilkins Who Has Facilitated Over 700 Treatments | Part 9


The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.

How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8


The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.

Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7


The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."

Psychedelics


A Doctor Explains How Prescribing Ketamine For Depression Works


We spoke with an experienced psychiatrist about how exactly prescribing ketamine for depression works.

Some colleges just don’t understand harm reduction


Clashes between SSDP and New College administrators represent growing confusion about handling harm reduction on campuses

What happens when you give an octopus MDMA?


A team of researchers bathed octopuses in MDMA. Here's what they learned.

A Conversation about Intersectionality in the Psychedelic Community


A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.

Cartoon Dystopia: 25I-NBOMe and Why You Should Test Your LSD


Like the vast majority of psychonauts, I didn’t use a chemical reagent to verify I was taking LSD, even though I had been active in harm reduction work for three years prior and was aware of testing kits.

Adam Strauss on Ketamine for OCD, Trip Sitters, and The Mushroom Cure Los Angeles


Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.

How should we be teaching students about drugs?


Rhana Hashemi is the site coordinator for drug and alcohol programs and services for Oakland Unified School District. But, to her students, she is just “the drug lady.”

How to meditate on psychedelics with Vincent Horn of Meditate.io


Vincent Horn of Meditate.io talks about psychedelics and meditation.

For someone who hasn’t taken a psychedelic drug it can be difficult to imagine what it’s like.


Think of a glass of water: under normal circumstances you might think ‘I drink water when I’m thirsty’. But when consuming a psychedelic substance you might think ’water is the essence of life’.

Salvinorin A. Is it possible to have a truly powerful painkiller that is not addictive?


We need new drugs. The opioid epidemic gripping the United States has brought into public awareness a problem that has bedeviled the world of medical science for decades: is it possible to have a truly powerful painkiller that is not addictive?

Becoming a Psychedelic Researcher: Alan Kooi Davis


Why researchers like Alan Kooi Davis — the newest addition to the Johns Hopkins psychedelic research team — decide to devote their careers to studying psychedelics.

We talked with a researcher using psilocybin for cocaine addiction in Alabama


I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.

LSD Cured My Eating Disorder


As a teenager, I was taking ten milligrams of Ritalin daily. Later, I grew to love the way these pills made it easier for me not to eat.

We now call ‘bad trips’ ‘challenging experiences’. Here’s why that’s misguided.


Renaming adverse effects of psychedelic drugs as “challenging experiences” minimizes, almost trivializes, their negative effects.

Psychedelics and the Full-Fluency Phenomenon


I first discovered the potential psychedelics have for treating stuttering during an experience with psilocybin mushrooms.

Is Ibogaine the Cure for Opioid Addiction? It’s Not That Simple. | Part 11


The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.

Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10


The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.

How Safe is Ibogaine? We Asked Clare Wilkins Who Has Facilitated Over 700 Treatments | Part 9


The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.

How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8


The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.

Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7


The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."